Latest papers

Marker metabolites can be therapeutic targets as well.

[Take nothing for granted....what to do when accused of polypragmasy]

Practice brief. Managing an effective query process.

[Impact of adverse events on the practices of 15 general practitioners]

Systemic antibiotics and tooth loss in periodontal disease.

Medicine. Life cycle of translational research for medical interventions.

HIPAA administrative simplification: modification to medical data code set standards to adopt ICD-10-CM and ICD-10-PCS. Proposed rule.

Communicating the benefits and harms of treatments.

Symposium on advances in therapy.

The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics.

Osteochondral flap avulsion fracture in a child with forearm compartment syndrome.

Hereditary breast cancer: new genetic developments, new therapeutic avenues.

Design of a 'day 3 bundle' to improve the reassessment of inpatient empirical antibiotic prescriptions.

[Practical guideline for the management of adverse events associated with BCG installations]

A salutogenic interpretation of the Ottawa Charter.

The healthy type. The therapeutic value of blogging becomes a focus of study.

[Central serous chorioretinopathy (CSC) and corticosteroids]

[Specialized therapeutic care in the A.A. VishnevskiÄ­ Central Military Clinical Hospital]

A careful disorderliness in the proteome: sites for interaction and targets for future therapies.

MicroRNAs make big impression in disease after disease.